HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Internet Marketers' Cancer, Arthritis Claims Targeted By FTC

This article was originally published in The Tan Sheet

Executive Summary

FTC is taking action against three Internet retailers making unsupported claims for their supplement products and using sophisticated Internet techniques to mislead consumers.

You may also be interested in...



Internet Content Equivalent To Advertising, Warrants FTC Oversight - WLF

Internet information is not necessary for the proper use of foods, dietary supplements or drugs, and should therefore be classified as advertising, the Washington Legal Foundation maintains in a citizen petition submitted to FDA April 13.

FTC "Surf Days" Turn Up 900 Fraudulent Sites, Will Release Results Soon

The Federal Trade Commission is preparing to release the results of a second series of "surf days" investigating fraudulent health care products and services promoted over the Internet.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS132709

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel